Impact of C-reactive protein on cardiovascular risk in adolescents;Impacto da proteína-C reativa no risco cardiovascular de adolescentes

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 5, 2010, Pages 585-591

  Da Silva, Isis Tande ^a   Sanches, Letícia Bertoldi ^a   Mello, Ana Paula De Queiroz ^a   Damasceno, Nágila Raquel Teixeira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescent; C reactive protein; Nutritional status; Obesity; Overweight; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ADOLESCENT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL;

EID: 77953782990     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2010005000027     Document Type: Article

References (39)

1. Muennig P. The body politic: the relationship between stigma and obesity-associated disease. BMC Public Health. 2008; 21 (8): 128. (Pubitemid 351712909)
2. Haslam DW, James WPT. Obesity. Lancet. 2005; 366 (9462): 1197-209.
3. Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008; 32 (9): 431-7.
4. Organização Pan-Americana da Saúde / Organização Mundial da Saúde. Doenças crônico-degenerativas e obesidade: estratégia mundial sobre alimentação saudável, atividade física e saúde. Brasília: Ministério da Saúde. 2002.
5. Instituto Brasileiro de Geografia e Estatísticas (IBGE). Pesquisa de orçamentos familiares no Brasil, 2002/2003. Antropometria e análise do estado nutricional de crianças e adolescentes no Brasil. Rio de Janeiro; 2006.
6. Yamamoto-Kimura L, Posadas-Romero C, Posadas-Sánchez R, Zamora-González J, Cardoso-Saldaña G, Mendez Ramírez I. Prevalence and interrelations of cardiovascular risk factors in urban and rural Mexican adolescents. J Adolesc Health. 2006; 38 (5): 591-8.
7. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350 (23): 2362-74.
8. Soriano-Guillén L, Hernández-García B, Pita J, Dominguez-Garrido N, Rio- Camacho GD, Rovira A. High sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol. 2008; 159 (1): R1-4. (Pubitemid 351969137)
9. Lazar MA. How obesity causes diabetes: not a tall tale. Science. 2005; 307 (5708): 373-5.
10. Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol. 2008; 216 (1): 3-13. (Pubitemid 351813090)
11. Sebeková K, Somoza V, Jarcusková M, Heidland A, Podracká L. Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int J Pediatr Obes. 2009; 4 (2): 112-8.
12. Greenberg AS, Obrin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006; 83 (2): 461S-465S.
13. National Center for Health Statistics (NCHS): Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion. May, 2000. [Acessed on 2008 Feb 10]. Available from: http://www.cdc.gov/growthcharts.
14. Brasil. Resolução n. 196, de 10 de outubro de 1996. Dispõe sobre as normas nacionais de ética em pesquisa com humanos. Brasília: Conselho Nacional de Saúde. 1999.
15. Friedewald WT, Levi RI, Fredrickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparatives ultracentrifuge. Clin Chem. 1972; 18 (6): 499-502.
16. Sanches LB, Silva IT, Paz AFS, Fisberg M, Cintra IP, Villar BS, et al. Auto-anticorpos anti-LDLox e sua correlação com o perfil lipídico e o estado nutricional de adolescentes. Jornal de Pediatria. 2008; 84 (3): 258-63.
17. SPSS Incorporation. Statistical package for the social science for windows student version/ SPSS (computer program) release 15.0 Chicago: marketing department, 2000.
18. Xu C, Yang X, Zu S, Han S, Zhang Z, Zhu G. Association between serum lipids, blood pressure, and simple anthropometric measures in an adult Chinese population. Arch Med Res. 2008; 39 (6): 610-7. (Pubitemid 352037463)
19. Seki M, SekiI MO, Seki MO, Lima AD, Onishi MH, Seki MO, et al. Estudo do perfil lipídico de crianças e jovens até 19 anos de idade. J Bras Patol Med Lab. 2001; 37: 247-51.
20. Carneiro JRI, Kushnir MC, Clemente ELS, Brandão MG, Gomes MB. Obesidade na adolescência: fator de risco para complicações clínicometabólicas. Arq Bras Endocrinol Metab. 2000; 44 (5): 390-6.
21. Lima SCVC, Arrais RF, Almeida MG, Souza ZM, Pedrosa LFC. Plasma lipid profile and lipid peroxidation in overweight or obese children and adolescents. J Pediatr. 2004; 80 (1): 23-8.
22. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation. 2005; 111 (15): 1985-91.
23. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004; 28: 833-41.
24. Giuliano ICB, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FH. Sociedade Brasileira de Cardiologia. I Diretriz de prevenção de aterosclerose na infância e na adolescência. Arq Bras Cardiol. 2005; 85 (supl 6): 1-36.
25. Brotons C, Ribeira A, Perich RM, Abrodos D, Magna P, Pablo S, et al. Worldwide distribution of blood lipids and lipoproteins in childhood and adolescence: a review study. Atherosclerosis. 1998; 139 (1): 1-9.
26. Lambert M, Delvin EE, Levy E, O'Loughlin J, Paradis G, Barnett T, et al. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol. 2008; 24 (7): 575-83.
27. Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, et al. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005; 147 (1): 62-6.
28. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade Systemic Inflammation in Overweight Children. Pediarics. 2001;107(1): E13.
29. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation. 2005; 111 (15): 1978-84.
30. Snodgrass JJ, Leonard WR, Tarskaia LA, McDade TW, Sorensen MV, Aleksee VP, et al. Anthropometric correlates of C-reactive protein among indigenous siberians. J Physiol Anthropol. 2007; 26 (2): 241-6.
31. Roh EJ, Lim JW, Ko KO, Cheon EJ. A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein. J Korean Med Sci. 2007; 22 (2): 192-7.
32. Akinci G, Akinci B, Coskun S, Bayindir P, Hekimsoy Z, Ozmen B. Evaluation of markers of inflammation, insulin resistance and endothelial dysfunction in children at risk for overweight. Hormones (Athens). 2008; 7 (2): 156-62.
33. Weinbrenner T, Schröder H, Escurriol V, Fito M, Elosua R, Vila J, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006; 83 (1): 30-5.
34. Denney-Wilson E, Hardy LL, Dobbins T, Okely AD, Baur LA. Body mass index, waist circumference, and chronic disease risk factors in Australian adolescents. Arch Pediatr Adolesc Med. 2008; 162 (6): 566-73.
35. Oliveira AC, Oliveira AM, Almeida MS, Silva AM, Adan L, Adeia AM. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth. J Pediatr. 2008; 152 (3): 337-42.
36. Guran O, Akalin F, Ayabakan C, Cereli FY, Haklar G. High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatr. 2007; 96 (8): 1214-9.
37. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999; 99 (2): 237-42.
38. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2003; 168 (2): 351-8.
39. Barros MR, Bertolami MC, Abdalla DS, Ferreira WP. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offspring. Atherosclerosis. 2006; 184 (1): 103-7.